Conjunctivitis or episcleritis and scleritis comprised the most common eye manifestations, while cataracts (11.7%) and visual ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate ...
The latest announcement is out from Adicet Bio ( (ACET) ).
David Zaccardelli, Pharm.D. joins Board as ChairRita Jain, M.D., joins Board as an Independent DirectorMIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...